Hospital
Hca Healthone LLC
Hca Healthone LLC was paid $10.94M by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 99284, emergency room visit (serious) — 48% of everything it billed.
33Billing provider infoHCA HEALTHONE LLC
DENVER, CO 80220
DENVER, CO 80220
33aNPI1023062098assigned 05/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.94M
24GClaims302,711
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#14 of 51
Median peer was paid$1.24M
This provider vs. median8.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,744 | $1.78M | |
| 2019 | 43,142 | $1.62M | |
| 2020 | 35,081 | $1.20M | |
| 2021 | 42,997 | $1.16M | |
| 2022 | 45,263 | $1.76M | |
| 2023 | 49,129 | $1.80M | |
| 2024incomplete | 39,355 | $1.62M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 48% | 50,905 | 43,403 | $5.24M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 35,656 | 31,416 | $3.93M |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.2% | 1,788 | 1,520 | $456K |
| 80053 | Comprehensive metabolic panel | 3.5% | 30,643 | 26,122 | $387K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 2,191 | 2,014 | $224K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 11,370 | 9,669 | $157K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 527 | 489 | $99K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,090 | 987 | $88K |
| 84484 | <1% | 5,783 | 4,215 | $73K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 523 | 486 | $42K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 221 | 192 | $35K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 259 | 215 | $30K |
46 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 29,307 | $27K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 467 | $25K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 315 | $21K |
| 80320 | <1% | 181 | $16K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 73 | $15K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 390 | $9K |
| 85027 | <1% | 50,392 | $9K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 65 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 17,663 | $6K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 109 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,755 | $3K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 30 | $3K |
| 76813 | <1% | 40 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 60 | $2K |
| 84703 | <1% | 5,837 | $2K | |
| 81003 | <1% | 2,360 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 51 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 7,089 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 36 | $1K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 13 | $1K |
| 76820 | <1% | 18 | $1K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 281 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 15,474 | $1K |
| 76801 | <1% | 12 | $1K | |
| 97597 | <1% | 39 | $905.76 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 669 | $811.54 |
| 84425 | <1% | 14 | $677.16 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 273 | $406.79 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,172 | $330.76 |
| 81001 | <1% | 1,569 | $212.89 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,660 | $140.15 |
| 36415 | Collection of venous blood by venipuncture | <1% | 84 | $96.15 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,546 | $94.41 |
| 82077 | <1% | 2,452 | $77.07 | |
| 83690 | <1% | 6,701 | $43.02 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,865 | $34.52 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 158 | $0.00 |
| 81025 | 0% | 32 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 842 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 452 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 69 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 27 | $0.00 |
| A9270 | Non-covered item or service | 0% | 65 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 14 | $0.00 |
| 87081 | 0% | 14 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPACK, NATALIE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Hca-Healthone, LLC Dba Rose Family Medicine Center | Denver, CO | $126K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.